Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Re: "A low-grade ovarian carcinoma case with coincident LOH of PTCH1 and BRCA1, and a mutation in BRCA1," Int J Gyn Pathol 2012 May;31: 264-271.

Köbel M, Ghatage P.

Int J Gynecol Pathol. 2013 Mar;32(2):176. doi: 10.1097/PGP.0b013e31826b4ea1. No abstract available.

PMID:
23370658
2.

In reply.

Maurac I, Sabol M, Car D, Cacev T, Levanat S.

Int J Gynecol Pathol. 2013 Mar;32(2):177. doi: 10.1097/01.pgp.0000427319.75615.d7. No abstract available.

PMID:
23370659
3.

A low-grade ovarian carcinoma case with coincident LOH of PTCH1 and BRCA1, and a mutation in BRCA1.

Maurac I, Sabol M, Musani V, Car D, Ozretic P, Kalafatic D, Oreskovic S, Babic D, Levanat S.

Int J Gynecol Pathol. 2012 May;31(3):264-71. doi: 10.1097/PGP.0b013e31823b6f0f.

PMID:
22498944
4.

Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.

Otis CN, Krebs PA, Quezado MM, Albuquerque A, Bryant B, San Juan X, Kleiner D, Sobel ME, Merino MJ.

Hum Pathol. 2000 Feb;31(2):233-8.

PMID:
10685639
5.

Increased incidence of brain metastases in BRCA1-related ovarian cancers.

Sekine M, Yoshihara K, Komata D, Haino K, Nishino K, Tanaka K.

J Obstet Gynaecol Res. 2013 Jan;39(1):292-6. doi: 10.1111/j.1447-0756.2012.01961.x. Epub 2012 Aug 13.

PMID:
22889437
6.

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.

Bruchim I, Amichay K, Kidron D, Attias Z, Biron-Shental T, Drucker L, Friedman E, Werner H, Fishman A.

Int J Gynecol Cancer. 2010 Oct;20(7):1148-53. doi: 10.1111/IGC.0b013e3181ef622d.

PMID:
21206239
7.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

PMID:
12096084
8.

Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.

Byrom J, Mudaliar V, Redman CW, Jones P, Strange RC, Hoban PR.

Int J Oncol. 2004 May;24(5):1271-7.

PMID:
15067351
9.

Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.

Quezado MM, Moskaluk CA, Bryant B, Mills SE, Merino MJ.

Hum Pathol. 1999 Feb;30(2):203-7.

PMID:
10029450
10.

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.

Wang C, Horiuchi A, Imai T, Ohira S, Itoh K, Nikaido T, Katsuyama Y, Konishi I.

J Pathol. 2004 Feb;202(2):215-23.

PMID:
14743504
11.

Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.

Pedersen BS, Konstantinopoulos PA, Spillman MA, De S.

Genes Chromosomes Cancer. 2013 Sep;52(9):794-801. doi: 10.1002/gcc.22075. Epub 2013 May 28.

12.

Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.

Huang LW, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC.

Am J Clin Pathol. 2000 Jul;114(1):93-9.

PMID:
10884804
13.

Preventing future cancers by testing women with ovarian cancer for BRCA mutations.

Kwon JS, Daniels MS, Sun CC, Lu KH.

J Clin Oncol. 2010 Feb 1;28(4):675-82. doi: 10.1200/JCO.2008.21.4684. Epub 2009 Oct 19.

PMID:
19841329
14.

Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.

Bandera CA, Muto MG, Welch WR, Berkowitz RS, Mok SC.

Oncogene. 1998 Jul 2;16(26):3455-9.

15.

BRCA1 mutations in familial ovarian cancer.

Lallas TA, Buekers TE, Buller RE.

Mol Genet Metab. 1999 Aug;67(4):357-63.

PMID:
10444347
16.

Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.

Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS, et al.

Clin Cancer Res. 1995 May;1(5):539-44.

17.

[Mutation of breast cancer susceptibility gene in ovarian cancer and its clinical significance].

Shi H, You Z, Guo Y.

Zhonghua Fu Chan Ke Za Zhi. 1998 Nov;33(11):676-8. Chinese.

PMID:
10806719
18.

Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.

Rio PG, Pernin D, Bay JO, Albuisson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ, Bignon YJ.

Int J Oncol. 1998 Oct;13(4):849-53.

PMID:
9735416
19.

Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.

Lassus H, Laitinen MP, Anttonen M, Heikinheimo M, Aaltonen LA, Ritvos O, Butzow R.

Lab Invest. 2001 Apr;81(4):517-26.

PMID:
11304571
20.

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KH.

Gynecol Oncol. 2011 Feb;120(2):229-32. doi: 10.1016/j.ygyno.2010.10.033. Epub 2010 Dec 3.

PMID:
21126756

Supplemental Content

Support Center